ModelEdge

Filing Type	S-4/A
Filing Date	8/9/2023
Updated	8/10/23, 11:30 AM

Filing

Earnings Release

Exhibits

EX-5.1OPINION OF GIBSON, DUNN & CRUTCHER LLP, COUNSEL OF COHBAR, INC

EX-10.27EXCLUSIVE LICENSE AGREEMENT, DATED MARCH 29, 2019, BETWEEN MORPHOGENESIS, INC. AND H. LEE MOFFITT CANCER AND RESEARCH INSTITUTE, AS AMENDED

EX-10.28EXCLUSIVE LICENSE AGREEMENT, DATED APRIL 23, 2021, BETWEEN MORPHOGENESIS, INC. AND H. LEE MOFFITT CANCER AND RESEARCH INSTITUTE, AS AMENDED

EX-10.29RESTATED AND AMENDED EXCLUSIVE LICENSE AGREEMENT, DATED SEPTEMBER 7, 2022, BETWEEN MORPHOGENE-SIS, INC. AND WEST VIRGINIA RESEARCH CORPORATION

EX-10.30ASSET PURCHASE AGREEMENT, DATED JANUARY 26, 2023, BETWEEN TUHURA BIOPHARMA INC. AND MORPHOGENESIS, INC

EX-23.1CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF COHBAR, INC

EX-23.2CONSENT OF CHERRY BEKAERT LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF MORPHOGENESIS, INC